Persistent HIV-1 expression and microglia dysfunction

HIV-1 持续表达和小胶质细胞功能障碍

基本信息

  • 批准号:
    10327546
  • 负责人:
  • 金额:
    $ 75.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT/PROJECT SUMMARY Microglia are long-lived central nervous system (CNS)-resident innate immune cells that have critical immune surveillance functions and homeostatic functions in the brain including clearance of pathogens and maintaining integrity of neuronal synapses. Microglia are targeted by HIV, have been proposed to be a reservoir for HIV persistent infection and are mediators of HIV-associated inflammation and neuropathogenesis. Importantly, microglia dysfunction is proposed to contribute to HIV associated neurodegeneration and inflammation even when HIV replication is suppressed during antiretroviral treatments. The mechanisms, direct or indirect, that drive microglia to promote inflammation during HIV infection have not been elucidated. In this study, we will utilize a primary microglia-neuron coculture model derived from pluripotent stem cells to test the hypothesis that HIV in microglia establishes persistently infected microglia that express aberrant viral RNAs, including those that retain intronic sequences, which mediate inflammasome activation to drive microglia dysfunction, CNS inflammation and neuronal injury. Our preliminary data supporting our hypothesis includes results demonstrating that primary macrophages harbor defective HIV proviruses and, despite harboring deletions and mutations that attenuate virus production, generate HIV RNAs. Furthermore, our previous work established the potential role of HIV intron containing RNA in activating inflammatory activities in macrophages and microglia. Specific questions addressed in this proposal include: 1) what is the status of proviruses in HIV infected microglia; 2) what mechanisms drive persistent expression of HIV RNA in microglia; and 3) what are the mechanisms that trigger inflammasome activation in HIV-activated macrophages? Completion of this project will provide general insights into the impact of HIV-1 persistence and expression in the context of microglia. Importantly, these studies will provide insights into mechanisms that contribute to HIV-1 CNS comorbidities which persist even with ART and could lead to new targets and strategies for treatments that will improve the lives of people living with HIV.
摘要/项目总结 小胶质细胞是长寿命的中枢神经系统(CNS)固有免疫细胞,其具有关键的免疫调节作用。 脑中的监视功能和稳态功能,包括病原体的清除和维持 神经元突触的完整性小胶质细胞是HIV的靶细胞,被认为是HIV的储存库 持续感染,是HIV相关炎症和神经发病机制的介质。重要的是, 小胶质细胞功能障碍被认为有助于HIV相关的神经变性和炎症, 在抗逆转录病毒治疗期间,艾滋病毒复制受到抑制。直接或间接的机制, 驱动小胶质细胞促进HIV感染期间的炎症尚未阐明。在这项研究中,我们将 利用来源于多能干细胞的原代小胶质细胞-神经元共培养模型来检验假设 小胶质细胞中的HIV建立了表达异常病毒RNA的持续感染的小胶质细胞,包括 保留内含子序列的那些,其介导炎性体活化以驱动小胶质细胞功能障碍, CNS炎症和神经元损伤。我们的初步数据支持我们的假设包括结果 表明原代巨噬细胞携带有缺陷的HIV前病毒,尽管携带有缺失, 减弱病毒产生的突变,产生HIV RNA。此外,我们以前的工作建立了 含有HIV内含子的RNA在激活巨噬细胞和小胶质细胞炎症活动中的潜在作用。 本提案中涉及的具体问题包括:1)在HIV感染者中, 2)是什么机制驱动HIV RNA在小胶质细胞中持续表达; 3) HIV激活的巨噬细胞中触发炎性小体激活的机制?完成本项目 将提供对HIV-1持续存在和表达的影响的一般见解, 小胶质细胞重要的是,这些研究将提供有助于HIV-1的机制的见解 CNS合并症即使在ART治疗下也持续存在,可能导致新的靶点和策略, 这些治疗将改善艾滋病毒感染者的生活。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SURYARAM GUMMULURU其他文献

SURYARAM GUMMULURU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SURYARAM GUMMULURU', 18)}}的其他基金

Persistent HIV-1 expression and microglia dysfunction
HIV-1 持续表达和小胶质细胞功能障碍
  • 批准号:
    10624911
  • 财政年份:
    2021
  • 资助金额:
    $ 75.94万
  • 项目类别:
Persistent HIV-1 expression and microglia dysfunction
HIV-1 持续表达和小胶质细胞功能障碍
  • 批准号:
    10448401
  • 财政年份:
    2021
  • 资助金额:
    $ 75.94万
  • 项目类别:
Persistent HIV expression induced type I IFN responses and inflammaging
持续的 HIV 表达诱导 I 型 IFN 反应和炎症
  • 批准号:
    10165448
  • 财政年份:
    2018
  • 资助金额:
    $ 75.94万
  • 项目类别:
Persistent HIV expression induced type I IFN responses and inflammaging
持续的 HIV 表达诱导 I 型 IFN 反应和炎症
  • 批准号:
    10396622
  • 财政年份:
    2018
  • 资助金额:
    $ 75.94万
  • 项目类别:
Persistent HIV expression induced type I IFN responses and inflammaging
持续的 HIV 表达诱导 I 型 IFN 反应和炎症
  • 批准号:
    9750592
  • 财政年份:
    2018
  • 资助金额:
    $ 75.94万
  • 项目类别:
GM3 Nanoparticles for Sustained Delivery of Anti-Retrovirals to Lymphatic Tissues
用于将抗逆转录病毒药物持续递送至淋巴组织的 GM3 纳米颗粒
  • 批准号:
    10056188
  • 财政年份:
    2017
  • 资助金额:
    $ 75.94万
  • 项目类别:
Engineering a 3D human neurovascular unit for investigating and countering neuroinflammatory mechanisms of HIV
设计 3D 人类神经血管单元来研究和对抗 HIV 的神经炎症机制
  • 批准号:
    9502663
  • 财政年份:
    2017
  • 资助金额:
    $ 75.94万
  • 项目类别:
GM3 Nanoparticles for Sustained Delivery of Anti-Retrovirals to Lymphatic Tissues
用于将抗逆转录病毒药物持续递送至淋巴组织的 GM3 纳米颗粒
  • 批准号:
    10292451
  • 财政年份:
    2017
  • 资助金额:
    $ 75.94万
  • 项目类别:
Elucidating Non-Virus Encoded HIV Capture through Artificial Virus Nanoparticles
阐明通过人工病毒纳米颗粒捕获非病毒编码的 HIV
  • 批准号:
    8682127
  • 财政年份:
    2013
  • 资助金额:
    $ 75.94万
  • 项目类别:
GLYCOSPHINGOLIPID COMPOSITIONS DURING INFECTION BY HIV TYPE 1 (HIV-1) PARTICLES
HIV 1型(HIV-1)颗粒感染期间的糖鞘脂组合物
  • 批准号:
    8365588
  • 财政年份:
    2011
  • 资助金额:
    $ 75.94万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 75.94万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 75.94万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.94万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.94万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 75.94万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.94万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 75.94万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 75.94万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 75.94万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.94万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了